Creative Financial Designs Inc Exact Sciences Corp Transaction History

Creative Financial Designs Inc

  • $1.11 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 26, 2022
SELL
$72.5 - $100.68 $18,922 - $26,277
-261 Closed
0 $0
Q3 2021

Oct 08, 2021
SELL
$90.24 - $124.05 $9,024 - $12,405
-100 Reduced 27.7%
261 $25,000
Q2 2021

Jul 27, 2021
BUY
$93.66 - $139.27 $9,366 - $13,927
100 Added 38.31%
361 $45,000
Q2 2020

Jul 23, 2020
BUY
$55.75 - $92.75 $14,550 - $24,207
261 New
261 $23,000

Others Institutions Holding EXAS

# of Institutions
610
Shares Held
166M
Call Options Held
1.93M
Put Options Held
1.23M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Creative Financial Designs Inc Portfolio

Follow Creative Financial Designs Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

News

Stay updated on Creative Financial Designs Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email